Russia's Sputnik V vaccine developers question neutrality of EU regulator, want apology | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Monday
December 11, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
MONDAY, DECEMBER 11, 2023
Russia's Sputnik V vaccine developers question neutrality of EU regulator, want apology

Coronavirus chronicle

Reuters
09 March, 2021, 04:25 pm
Last modified: 09 March, 2021, 04:27 pm

Related News

  • The yuan is finally showing some muscle in international trade
  • Russia does not recognise 'illegal' sanctions by West: Ambassador
  • G7 to phase in direct, indirect bans of Russian diamonds from 1 Jan
  • Russia's Putin, Saudi crown prince discuss further OPEC+ cooperation in whirlwind visit
  • Putin, flanked by Russian fighters, jets into Middle East to meet Saudi's MbS

Russia's Sputnik V vaccine developers question neutrality of EU regulator, want apology

“We demand a public apology from EMA’s Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V,” the vaccine developers wrote on the official Sputnik V Twitter account

Reuters
09 March, 2021, 04:25 pm
Last modified: 09 March, 2021, 04:27 pm
The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement.  Photo: Reuters
The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. Photo: Reuters

The developers of Russia's Sputnik V vaccine against Covid-19 on Tuesday questioned the neutrality of the European Medicines Agency (EMA) after an EMA official urged EU members to refrain from approving the Russian vaccine for now.

Christa Wirthumer-Hoche, the head of EMA's management board, told a talk show on Austrian broadcaster ORF on March 7 that she advised European Union countries against granting Sputnik V a national emergency authorisation while EMA was still reviewing the Russian vaccine's safety and effectiveness.

"We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V," the vaccine developers wrote on the official Sputnik V Twitter account.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"Her comments raise serious questions about possible political interference in the ongoing EMA review," they said.

The developers added that the vaccine had already been approved by 46 countries.

"After postponing Sputnik V review for months, EMA does not have the right to undermine (the) credibility of 46 other regulators that reviewed all of the necessary data," Sputnik V's developers said.

Sputnik V has already been approved or is being assessed for approval in three EU member states - Hungary, Slovakia and the Czech Republic. EU officials have said Brussels could start negotiations with a vaccine maker if at least four member countries request it.

Kirill Dmitriev, head of Russia's RDIF sovereign wealth fund, which markets Sputnik V abroad, told Italian television on Sunday it was collaborating with pharmaceutical company Adienne to produce the vaccine in Italy.

The Italian-Russian Chamber of Commerce later said there were plans for production to start in Italy in June and that the deal paved the way to create the first Sputnik V production facility in Europe.

EMA earlier this month said it would review data from ongoing trials of the vaccine until there was enough evidence for a formal marketing authorisation application.

Top News / World+Biz

Sputnik Covid-19 Vaccine / Russia / EU

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • File photo of Envoy Textile factory. Photo: Salauddin Ahmed Paulash/TBS
    Bangladeshi textile millers seek loan concession, increased LC limit
  • Prime Minister Sheikh Hasina. Sketch: TBS
    Bangladesh needs immediate climate funding to navigate future challenges: PM Hasina
  • Renata at a glance
    Renata puts footprint into Aussie pharma market

MOST VIEWED

  • Photo: Times of India
    Abir Hassan, first Bangladeshi to graduate from Indian Military Academy
  • 10m barrel oil, 300b cubic feet gas found in Sylhet
    10m barrel oil, 300b cubic feet gas found in Sylhet
  •  ZARA ATELIER. Collection 04; The Jacket. Photo: Collected
    When art imitates cruelty: Dissecting Zara’s latest shoot
  • Photo: euronews
    Apps that use AI to undress women in photos soaring in use
  • Two-thirds of LPG sellers hold on to bulk importers to stay afloat in dollar crisis
    Two-thirds of LPG sellers hold on to bulk importers to stay afloat in dollar crisis
  • BNP declares fresh round of blockade on Tuesday-Wednesday
    BNP declares fresh round of blockade on Tuesday-Wednesday

Related News

  • The yuan is finally showing some muscle in international trade
  • Russia does not recognise 'illegal' sanctions by West: Ambassador
  • G7 to phase in direct, indirect bans of Russian diamonds from 1 Jan
  • Russia's Putin, Saudi crown prince discuss further OPEC+ cooperation in whirlwind visit
  • Putin, flanked by Russian fighters, jets into Middle East to meet Saudi's MbS

Features

Shashtho Chaka – Healthcare on Wheels has two buses, they plan to use one bus for the urban slums and another one for remote areas in villages.  Photos: Courtesy

Shashtho Chaka: Driving healthcare up to the doorstep of the poor

4h | Panorama
Russia has become increasingly critically dependent on Beijing. Even state-owned refiners in India are being pressured by Russian oil suppliers to pay in yuan.
Photo: Bloomberg

The yuan is finally showing some muscle in international trade

3h | Panorama
Khandaker Hasib Rafin’s Starlet Glanza V is one of the finest examples of the model to roam around Dhaka’s streets. Photo: Akif Hamid

1999 Starlet Glanza V: The uncrowned prince

20h | Wheels
Jamal Jamaloo: The song, dance and magic

Jamal Jamaloo: The song, dance and magic

22h | Features

More Videos from TBS

Unemployment among Asian workers and Black men rises in November

Unemployment among Asian workers and Black men rises in November

20m | TBS World
Installation of 5% of target EFD machines in 3 years

Installation of 5% of target EFD machines in 3 years

20m | TBS Economy
Wealth and income of ministers and state ministers increased

Wealth and income of ministers and state ministers increased

15h | TBS Stories
Fake toll plaza on Indian highway

Fake toll plaza on Indian highway

14h | TBS World
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]